These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10937497)

  • 1. Diabetes-related autoantibodies and the selection of subjects for trials of therapies to preserve pancreatic beta-cell function in recent-onset type 1 diabetes.
    Dupré J; Mahon JL
    Diabetes Care; 2000 Aug; 23(8):1057-8. PubMed ID: 10937497
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers of beta cell function in type 1 diabetes mellitus.
    Vendrame F; Zappaterreno A; Dotta F
    Minerva Med; 2004 Apr; 95(2):79-84. PubMed ID: 15272242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials.
    Eisenbarth GS
    Curr Diab Rep; 2004 Apr; 4(2):85-6. PubMed ID: 15035966
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic issues in type 1 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2001 Dec; 24(12):2143-9. PubMed ID: 11723097
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.
    Taniguchi T; Okazaki K; Okamoto M; Seko S; Uchida K; Seino Y
    Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728
    [No Abstract]   [Full Text] [Related]  

  • 7. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G; Bazzigaluppi E; Mangili R; Bosi E; Bonifacio E
    Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
    [No Abstract]   [Full Text] [Related]  

  • 9. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoantibodies against insulin and beta-islet cells in pancreatic adenocarcinoma: a possible explanation for diabetes mellitus.
    Syrigos KN; Konstantoulakis MM; Fyssas I; Katsilambros N; Golematis BC
    Int J Cancer; 1996 May; 66(5):624-6. PubMed ID: 8647623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies in children and adolescents with insulin-dependent diabetes mellitus.
    d'Annunzio G; Caporali R; Lorini R
    Diabetes Res Clin Pract; 1994 Feb; 23(1):63-4. PubMed ID: 8013265
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-cell autoimmunity, genetic susceptibility, and progression to type 1 diabetes in unaffected schoolchildren.
    Kulmala P; Rahko J; Savola K; Vähäsalo P; Sjöroos M; Reunanen A; Ilonen J; Knip M
    Diabetes Care; 2001 Jan; 24(1):171-3. PubMed ID: 11194225
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune diagnostics in diabetes mellitus.
    Seissler J; Scherbaum WA
    Clin Chem Lab Med; 2006; 44(2):133-7. PubMed ID: 16475896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant results in the assay of cytoplasmic islet cell autoantibodies with ELISA and immunohistochemical techniques.
    Kohnert KD; Besch W; Rjasanowski I
    Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):447-9. PubMed ID: 7548454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Latent autoimmune diabetes in adults].
    Maioli M; Puddu L; Pes GM
    Clin Ter; 2006; 157(1):69-78. PubMed ID: 16669554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LADA--latent autoimmune diabetes in adults].
    Szelachowska M
    Endokrynol Pol; 2007; 58(3):246-51. PubMed ID: 17940991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus.
    van Deutekom AW; Heine RJ; Simsek S
    Diabet Med; 2008 Feb; 25(2):117-25. PubMed ID: 18028440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
    Costa A; Conget I; Casamitjana R
    Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients.
    Shervani NJ; Takasawa S; Uchigata Y; Akiyama T; Nakagawa K; Noguchi N; Takada H; Takahashi I; Yamauchi A; Ikeda T; Iwamoto Y; Nata K; Okamoto H
    Eur J Clin Invest; 2004 Nov; 34(11):752-8. PubMed ID: 15530148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.